CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 267 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $108,360 | -22.7% | 2,000 | 0.0% | 0.01% | -28.6% |
Q1 2024 | $140,220 | -21.5% | 2,000 | -6.5% | 0.01% | -22.2% |
Q4 2023 | $178,669 | +183.4% | 2,140 | 0.0% | 0.01% | +125.0% |
Q3 2023 | $63,045 | -9.7% | 2,140 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $69,807 | -12.4% | 2,140 | -5.5% | 0.00% | -20.0% |
Q1 2023 | $79,706 | -10.4% | 2,265 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $89,000 | -13.6% | 2,265 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $103,000 | – | 2,265 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |